Education event

Webinar Participant Information

Sterile Compounding Pharmacies — Planning, Construction and Licensing Guidance Webinar

Date: April 21, 2017
Time: 10:00 a.m. – 12:00 p.m., Pacific Time

Recording


Program recorded live on April 21, 2017

Overview

Effective January 2017, hospitals that perform sterile compounding must meet new regulatory requirements from the California State Board of Pharmacy. Beyond updating processes and procedures, hospitals will be required to improve or reconfigure facilities for ventilation, install new equipment for sterility and ensure employee protections.

This process is new and requires collaboration, coordination and a focused approach for successful implementation. CHA has gathered representatives from three California government entities — the Board of Pharmacy, Office of Statewide Health Planning and Development (OSHPD) Facilities Development Division and Department of Public Health Licensing and Certification Program — to share insights crucial to compliant implementation of the sterile compounding regulations.

Recommended for:
Chief operating officers, chief compliance officers, directors of pharmacies, plant managers, construction directors and managers, architects and engineers, inspectors of record.

Program supported by:
American Institute of Architects California Council

Materials

Print presentation slides for note-taking purposes:

To access the OSHPD Advisory Guide, visit www.oshpd.ca.gov/FDD/Training_Education/index.html.

Faculty

Christine Acosta, PharmD, Supervising Inspector, California State Board of Pharmacy

Paul A. Coleman, Deputy Director, Facilities Development Division, California Office of Statewide Health Planning and Development (OSHPD)

Diana Scaturro, Supervisor, Rapid Review Unit, Facilities Development Division, OSHPD

Robert Menét, PharmD, Chief Pharmaceutical Consultant, Licensing and Certification Program, California Department of Public Health

Commands